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Abstract 
Objective   Paediatric thyroid diseases requiring surgery is uncommon 
and is associated with a greater risk of complications than in adults. At 
present, the research to paediatric thyroidectomy is not adequate enough 
and less complete than in adults. Most of the published papers 
concentrated on one of these paediatric thyroid disorders. Our paediatric 
series were retrospectively analyzed to study the indications for 
thyroidectomy in paediatric patients. 
Patients and methods  From January 2002 to December 2010, 253 
paediatric patients (no more than 18 years old) with thyroid diseases 
underwent thyroid operations at the Department of Surgery, University of 
Pisa. Data were collected from patient medical records, and a database 
was established to record sex, age, type of operation, histological 
diagnosis, tumor size, tumor capsule infiltration, thyroid capsule 
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infiltration, multifocality, bilaterality, node metastases and TNM stages. 
These data were retrospectively analyzed to try to analyze the indications 
for thyroid surgery in paediatric patients. 
Results  In cases of thyroid malignancy total thyroidectomy without 
lymph-node dissection was performed in 75 cases, whereas a lymph-node 
dissection was performed in 72 cases. 45 patients with follicular adenoma 
underwent near total thyroidetomy or total thyroidectomy. 33 patients 
underwent near total thyroidetomy or total thyroidectomy for Graves’ 
disease. Lobectomies were performed in 28 patients with nodular goiter. 
There were no injuries to the recurrent laryngeal nerve (RLN). 
Hypocalcemia was the most common postoperative complication, 
occurring in 52 patients. All patients had normalization of their calcium 
levels within 3 months postoperatively. 
No patient showed any unexpected diagnosis, and all the preoperative 
indications were histologically confirmed except one MTC patient was 
diagnosed c cell hyperplasia postoperatively. Six pathological subtypes of 
PTC were present. 
In all thyroid diseases, a female predominance is evident. When further 
analyzing the different age-groups in patients with differentiated thyroid 
cancer, this predominance is still observed both in the group 0～12 and in 
the adolescent group 13～18. 
In all thyroid diseases, a progressive incidence of surgery is showed from 
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younger ages to older ones. This progressive incidence is still observed in 
patients with differentiated thyroid cancer. 
Mean tumor size in PTC, FTC and MTC was 2.2 cm, 3.3 cm and 0.8 cm, 
respectively. Tumor capsule infiltration was presented in 78.6% of PTC, 
100% of FTC and 66.7% of MTC, whereas infiltration of the thyroid 
capsule only occurred in 45% of PTC cases. Lymph-node metastases 
were found in 42.0% of PTC, 0% of FTC and 16.7% of MTC. Among 
variants of PTC, CV demonstrated the majority of cases of T3 or T4 
stages. DSV and FV respectively had the highest and the least  
proportion of T3 stage. 
PTC showed more lymph-node metastases than FTC and MTC. 
Unilateral or bilateral lymph-node metastases occurred in 31.3% of PTC. 
98.2% of lymph-node metastases occurred in PTC cohort. Among 
variants of PTC, CV demonstrated the majority of metastases. DSV and 
FV respectively had the highest and the least tendency of metastases. 
Conclusions  Indications for thyroidectomy in paediatric patients 
include thyroid cancer, Graves’ disease and non-cancerous nodules, and 
thyroid cancer accounts for the majority of the indications. Among the 
paediatric population, female sex and pubertal age are the most common 
targets for thyroid disorders. Female sex and pubertal age are risk factors 
of paediatric thyroid disorders. A paediatric surgeon is not essential when 
dealing with thyroid surgery in children, but the results are affected by the 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
5 
 
experience of the surgeon dealing with thyroid surgery. 
From an oncological point of view, our study confirms that papillary 
thyroid carcinoma in children shows more aggressiveness, higher stage at 
presentation, and is more prone to present with lymph-node metastases 
than both follicular and medullary thyroid carcinoma, and than the same 
disease in the adult population. In particular, the diffuse sclerosing variant 
shows the most aggressive features, and the follicular one seems to have 
the less aggressive features. 
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Symbolic description 
( Alphabetic Order ) 
 
Abbreviation 
ATDs                                
CV                                      
DSV                     
DTC               
ETA                       
FMTC           
FNA                                
FTC              
FV         
GD              
MEN                    
MMI                       
MTC                
PDV                  
PTC                           
RAI   
RET                     
 
Full Name 
Antithyroid Drugs 
Classical Variant 
Diffuse Sclerosing Variant 
Differentiated Thyroid Carcinoma 
European Thyroid Association 
Familial Medullary Thyroid Carcinoma 
Fine Needle Aspiration 
Follicular Thyroid Carcinoma 
Follicular Variant 
Graves’ Disease 
Multiple Endocrine Neoplasia 
Methylimidazole 
Medullary Thyroid Carcinoma 
Poorly Differentiated Variant 
Papillary Thyroid Carcinoma 
Radio Active Irradiation 
Proto Oncogene Rearranged During 
Transfection 
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RLN                          
SSKI                     
SV                        
TCV                           
TNM                      
TSH                 
US                              
Recurrent Laryngeal Nerve 
Super Saturated Potassium Iodine 
Solid Variant 
Tall Cell Variant 
Tumor Node Metastases 
Thyroid Stimulating Hormone 
Ultrasonography 
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Indications for Thyroidectomy in Paediatric Patients 
 
Introduction 
Paediatric thyroid diseases requiring surgery is uncommon and is 
associated with a greater risk of complications than in adults. Thyroid 
disorders requiring surgery in the paediatric population include Grave’s 
disease (GD), thyroid cancer and non-cancerous nodules.  
When surgery is performed for patients for GD, near-total or total 
thyroidectomy is recommended. When surgery is performed for patients 
with thyroid cancer, total thyroidectomy is recommended, and central 
or/and lateral lymph-node compartment dissection may be needed if there 
is preoperative localization in these regions. Isolated nodules without 
preoperative evidence of cancer may be treated by lobectomy or 
near-total thyroidectomy. Importantly, complication rates for 
thyroidectomy are considerably higher in children than adults. Therefore, 
paediatric patients who require thyroid surgery should be managed by an 
experienced thyroid surgical team, but a paediatric surgeon is not 
essential
[1-3]
. 
The treatment of GD in children, though, remains controversial, and 
treatment practices vary widely among institutions and practitioners 
[10]
. 
Studies of paediatric Graves’ disease show a range of remission rates 
between 25 and 65% 
[4-9]
. Longer periods of time are usually required to 
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achieve remission in children than in adults. The time limit for maximum 
benefit from antithyroid medications in children is controversial 
[4]
. One 
study even suggested an approximately 25% remission rate for every 2 
years of continued antithyroid medication therapy 
[10]
. However, 35–60% 
of patients may experience a relapse after medications are discontinued 
[4]
. 
So it is difficult to determine when definitive treatment in paediatric 
patients should take place. 
Definitive treatment of Graves’ disease consists of RAI ablation and 
surgery. Patients as young as one year of age have been treated with 
131
I 
with excellent outcomes. The overall remission rates of 
131
I in children in 
published studies exceed 95% 
[11]
. Although RAI is proved to be safe and 
is used progressively in younger ages, there is also a theoretical risk of 
thyroid cancer if there’s residual thyroid tissue in young children after 
RAI treatment. Risks of thyroid cancer after external irradiation are 
highest in children less than five years of age and progressively decline 
with advancing age 
[11-14]
. In addition to thyroid cancer risks, potential 
influences of 
131
I therapy on other cancers need to be considered as 
131
I 
therapy results in low level whole body radiation exposure. 
Surgery is preferred in young children (<5 years) when definitive therapy 
is required and can be performed by an experienced thyroid surgeon. In 
individuals with large thyroid glands (>80 g), the response to 
131
I may be 
poor 
[15, 16]
 and surgery is recommended for these patients. 
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In preparation for surgery, the paediatric patients should be rendered 
euthyroid reasonably to prevent perioperative thyroid storm 
[17]
.This is 
typically done with MMI for one or two months. Even with optimal 
treatment it is typical for the child to have a suppressed serum TSH level 
at the time of surgery. It is also important to have an experienced 
paediatric anesthesiologist to help manage these patients. Two weeks 
before surgery Super Saturated Potassium Iodine (SSKI) solution should 
be administered to decrease the vascularity and increase the firmness of 
thyroid gland 
[18,19]
. 
For Grave’s disease near-total or total thyroidectomy is recommended, as 
subtotal thyroidectomy is associated with a higher relapse rate. The 
thyroid gland in Graves’ disease may be extremely vascular and prone to 
bleeding intraoperatively and postoperatively. The surgeon must be 
employ meticulous hemostasis and avoid leaving significant thyroid 
remnants in vivo. The pyramidal lobe must be completely excised as it 
commonly hypertrophies and if left in situ will recur as a midline neck 
mass and hyperthyroid state 
[20]
. In addition, the parathyroid glands are 
vulnerable and can be easily injured when they are mobilized off a 
hyperthyroid thyroid gland 
[21]
. Parathyroid injury coupled with 
long-standing hyperthyroidism with its associated increased bone 
turnover render these patients at high risk for postoperative 
hypocalcemia. 
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Differentiated thyroid carcinoma is the most common paediatric 
endocrine tumor, constituting 0.5% to 3% of all childhood 
malignancies
[22]
. Differentiated thyroid carcinoma has been studied 
extensively in adults; however, the paediatric literature on differentiated 
thyroid carcinoma is much less complete. Compared with adults, children 
with differentiated thyroid cancer (DTC) present with more extensive 
disease 
[23-32]
. Lymph-node involvement at diagnosis is seen in 40-90% of 
children 
[24-33]
, compared with 20-50% of adults 
[34]
. The prevalence of 
distant metastases, most commonly lung, is 20-30% in children vs. 2% in 
adults 
[23-32, 35]
. Multifocal disease is more common in children than adults 
and is seen in about 40% of childhood PTC cases. In general, DTC with 
onset less than 10 years of age appears to have higher recurrence and 
mortality rates than presentation at older ages 
[35, 36]
, and DTC onset older 
than 10 years-of-age behaves similar to young adults 
[35]
. DTC is 
generally more widespread at presentation and more likely to recur in 
younger than older children
 [37]
. Other investigations have found that DTC 
has similar biological properties in younger children and adolescents 
[38]
. 
Surgical options for DTC include total thyroidectomy, near-total 
thyroidetomy, subtotal thyroidetomy, or lobectomy
[39]
. Anatomically the 
thyroid is divided into the right and left lobes, which are connected by the 
isthmus. The thyroid gland is encased by a capsule. A total thyroidectony 
refers to a complete resection of the thyroid gland via an extracapsular 
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dissection 
[40,41]
. If it is determined intraoperatively that a complete 
extracapsular dissection will result in a irreversible damage to either the 
recurrent laryngeal nerve (RLN) or parathyroid glands, the capsule can be 
entered and a small amount of thyroid tissue can be left in situ to avoid 
injury to either the RLNs or parathyroid glands, a procedure referred to as 
a near-total thyroidectomy 
[40, 41]
. A subtotal thyroidectomy refers to 
removal of the ipsilateral lobe, the isthmus and the media portion of the 
contralateral thyroid lobe 
[40,41]
. The blood supply to the remaining thyroid 
tissue is left intact, along with the parathyroid gland thus theoretically 
reducing the risk of postoperative hypoparathyroidism
 [40, 41]
. Additionally, 
dissection near RLN is avoided thus reducing the chance of damaging the 
nerve. The remaining thyroid tissue is vascularized and typically remains 
metabolically active avoiding or reducing the need for thyroid hormone 
replacement. A lobectomy refers to an extracapsular resection of an 
anatomic lobe or anatomic lobe and isthmus. These operations can be 
performed without lymph-node dissection, the selective removal of 
lymph-nodes that appear pathological at surgery, or compartmental 
lymph-node dissection, during which all lymph-nodes in a region are 
systematically removed “en block” irrespective of gross appearance [39, 42]. 
The extent of lymph-node surgery has been the subject of attention
[43,44]
. 
Cancer recurrence most occurs in lymph-nodes in the laryngotracheal 
region
 [45]
. In children and adults, the greater the lymph-node involvement 
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in recurrent disease, the greater is the risk of distant metastases and 
mortality
 [27, 29-31]
. Lymph-node metastasis is a pervasive component of 
DTC in children, as up to 90% of children with DTC will have nodal 
disease. Importantly in up to 50% of cases, DTC involvement of 
lymph-node is not detectable by preoperative ultrasonography
 [46. 47]
. An 
important consideration in advocating for routine central lymph-node and 
selected lateral and contralateral lymph-node compartments dissection is 
the increased risk of complications associated with the procedure vs. total 
thyroidectomy alone. Potential complications include damage to the 
recurrent laryngeal nerves, external branches of the superior laryngeal 
nerves and parathyroid glands, as well as hemorrhage, and infection 
[48]
. 
Another not worthy consideration is the added complexity of re-operation 
when macroscopic residual or recurrent disease is detected. Re-operation 
at previous neck surgical sites is associated with substantially higher 
complication rates related to local scar tissue and altered post-surgical 
anatomy 
[49, 50]
.  
Medullary thyroid cancer (MTC) is an uncommon type of aggressive 
thyroid cancer that does not respond to systemic radioactive iodine, an 
effective treatment for most other types of thyroid cancer. This cancer’s 
aggressive biological behavior also diminishes the effectiveness of 
surgical therapy, and there is currently no standard effective 
chemotherapy for this cancer. The etiology of MTC is well documented 
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in the literature; it may occur sporadically or present as part of an 
autosomal dominant inherited disorder. If inherited, MTC is 100% 
penetrant, although the age of onset is variable 
[51–55]
. Hereditary MTC is 
a component of two genetic syndromes, including multiple endocrine 
neoplasia type 2 (MEN 2A and MEN 2B) and familial medullary thyroid 
carcinoma (FMTC). MEN type 2A (MEN 2A) includes multicentric and 
often bilateral MTC, unilateral, or bilateral pheochromocytoma and 
hyperparathyroidism caused by parathyroid hyperplasia or adenoma. 
Some patients have cutaneous lichen amyloidosis. MEN type 2B (MEN 
2B) includes MTC, pheochromocytoma, mucosal neuromas of the 
alimentary tract and subconjunctival areas, and skeletal abnormalities 
including marfanoid habitus, pectus excavatum, and slipped capital 
femoral epiphysis. MTC in MEN 2B presents at younger ages than in 
MEN 2A and in FMTC; and frequently it is detectable in infancy. MEN 
2B-associated MTC also is more aggressive than MTC associated with 
MEN 2A or with familial thyroid carcinoma 
[51–56]
. 
In MEN 2 and in familial medullary thyroid carcinoma, total 
thyroidectomy is the surgical choice. If the patient is a known RET carrier, 
thyroidectomy is prophylactic if performed before the calcium 
stimulation test is positive. In RET-positive MEN 2A children, 
thyroidectomy should be performed before age 5, and in RET-positive 
MEN 2B patients, thyroidectomy should be performed within the first 
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few months of life. Calcitonin levels should be measured before surgery 
and can be used thereafter as a tumor marker. A total thyroidectomy 
should be accompanied by central neck dissection. If central nodes are 
positive, then the dissection of lateral compartments is needed. 
Postoperatively, patients are started on regular thyroid replacement 
therapy but not to suppress TSH levels because the C cells are not 
TSH-responsive. Calcium-stimulated calcitonin measurements should be 
performed postoperatively and at regular intervals thereafter for 
follow-up of medullary tumors. If basal calcitonin levels are elevated, 
then stimulation testing is unnecessary 
[56]
. 
In chemically euthyroid patients, benign nodules can be observed unless 
there is a diagnostic dilemma or they are causing symptoms. Nodules can 
cause symptoms due to size or elaboration of excessive amounts of 
thyroid hormone. If a patient develops symptoms of compression related 
to mass effect, such as discomfort or pain (globus sensation), dysphagia, 
dysphonia, or difficulty breathing, particularly when lying flat, surgery 
should be considered. Uninodular goiters are amenable to lobectomy, 
while multinodular goiters require near-total or total thyroidectomy. 
Metabolically active nodules will present with increased uptake on a 
thyroid radioisotope scan. Toxic adenomas are autonomously functioning 
benign tumors that cause symptomatic hyperthyroidism. The true 
incidence of toxic adenomas in children is low enough to preclude 
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epidemiologic estimates 
[57]
. In the case of children with solitary or 
uninodular toxic adenomas, thyroid lobectomy is the recommended 
procedure (or isthmusectomy if the toxic nodule is in the isthmus, which 
is rare). Subtotal lobectomy or nodulectomy are not adequate resections, 
and risk recurrence of the disease. As in the case of Graves’ disease, these 
patients should be rendered biochemically and clinically euthyroid prior 
to surgery. The risk of lobectomy includes bleeding and recurrent 
laryngeal nerve injury.  
At present, the research to paediatric thyroidectomy is not adequate 
enough and less complete than in adults. Most of the published papers 
concentrated on one of these paediatric thyroid disorders. Our paediatric 
series were retrospectively analyzed to study the indications for 
thyroidectomy in paediatric patients.  
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Patients and methods 
From January 2002 to December 2010, 253 paediatric patients (no more 
than 18 years old) with thyroid diseases underwent thyroid operations at 
the Department of Surgery, University of Pisa. The mean age of the 
patients was 15.1 years (range of 5-18 years), and female-male ratio was 
202 (79.8%)/51(20.2%). None of the patients identified had a history of 
previous neck irradiation or operation. 
The preoperative diagnosis consisted of differentiated thyroid cancer 
(papillary, follicular and medullary) in 147 cases (58.1%), Graves’ disease 
in 33 cases (13.0%), follicular adenoma in 45 cases (17.8%), and nodular 
goiter in 28 cases (11.1%). 
Surgery consisted of lobectomy (for nodular goiter or adenoma), 
near-total thyroidectomy (for Grave’s disease or adenoma) and total 
thyroidectomy(for cancer or Grave’s disease), and lymph-node dissection 
was performed in malignant cases when lymph-node involvement was 
localized preoperatively by imaging studies and/or FNA, according to the 
current ETA guidelines. In cases of medullary thyroid cancer, the 
operation was a total thyroidectomy associated to prophylactic central 
neck dissection, if node metastases were not preoperatively evident. 
Data were collected from patient medical records, and a database was 
established to record sex, age, type of operation, histological diagnosis, 
tumor size, tumor capsule infiltration, thyroid capsule infiltration, 
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multifocality, bilaterality, node metastases and TNM stages. These data 
were retrospectively analyzed to try to analyze the indications for thyroid 
surgery in paediatric patients. 
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Results 
Surgical procedure    Based on the preoperative diagnosis, in cases of 
thyroid malignancy total thyroidectomy without lymph-node dissection 
was performed in 75 cases, whereas a lymph-node dissection was 
performed in 72 cases. 45 patients with follicular adenoma underwent 
near total thyroidetomy or total thyroidectomy. 33 patients underwent 
near total thyroidetomy or total thyroidectomy for Graves’ disease. 
Lobectomies were performed in 28 patients with nodular goiter. 
Surgical morbidity  There were 4 cases of damage to the recurrent 
laryngeal nerve (RLN) recorded, including 3 unilateral cases and one 
bilateral case. Hypocalcemia was the most common postoperative 
complication, occurring in 52 patients (20.6%). All patients were 
managed with oral calcium. 38 patients had normalization of their 
calcium levels within 6 months postoperatively, which is known as 
temporary hypocalcemia. Permanent hypocalcemia occurred in the other 
14 patients. 
Final histology  No patient showed any unexpected diagnosis, and all 
the preoperative indications were histologically confirmed except one 
MTC patient was diagnosed c cell hyperplasia postoperatively. The 
cohort of patients affected with differentiated thyroid cancer included 
131(89.1%) cases of PTC, 9(6.1%) cases of FTC, and 6(4.8%) cases of 
MTC, and one patient with c cell hyperplasia (Table 1).  
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Six pathological subtypes of PTC were present, including 71(54.2%) 
cases of classical variant (CV), 42 (32.1%) cases of follicular variant 
(FV), 9 (6.9%) cases of diffuse sclerosing variant (DSV), 6 (4.6%) cases 
of tall cell variant (TCV), 2 (1.5%) cases of poorly differentiated variant 
(PDV), and 1 (0.7%) case of solid variant (SV) (Table 1).  
Sex distribution  In all thyroid diseases, a female predominance is 
evident, as shown Figure 1.  
 
 
When further analyzing the different age-groups in patients with 
differentiated thyroid cancer, this predominance is still observed both in 
the group 0～12 (74.1%) and in the adolescent group 13～18 (82.3%) 
(Figure 2). 
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Age distribution    The distribution of the patients according to the age 
at operation is described in Figure 3. When further analyzing the different 
age groups (7～9, 10～12, 13～15, 16～18), the results show a 
progressive incidence of surgery, as shown in Figure 3. 
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In the different age groups the escalated ratios of PTC are expressed in 
Figure 4. 
 
 
The age distribution of different variants of PTC are shown in Figure5. 
 
 
Tumor features  Mean tumor size in PTC, FTC and MTC was 2.2 cm, 
3.3 cm and 0.8 cm, respectively. Tumor capsule infiltration was presented 
in 78.6% of PTC, 100% of FTC and 66.7% of MTC, whereas infiltration 
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of the thyroid capsule only occurred in 45% of PTC cases. Lymph-node 
metastases were found in 42.0% of PTC, 0% of FTC and 16.7% of MTC. 
All these data are summarized in Table 1. 
Table 1 Invasive features of carcinoma 
Carcinoma 
Size 
(cm) 
Tumor capsule  
Infiltration 
Thyroid capsule 
infiltration 
Multifocality Bilaterality 
Node 
Metastases 
PTC 2.2 103/131(78.6%) 59/131(45.0%) 58/131(44 %) 42/131(32.1%) 55/131(42.0%) 
CV 2.1 60/71(84.5%) 35/71(49.3%) 33/71(46.5%) 23/71(32.4%) 34/71(47.9%) 
   FV 2.1 25/42(59.5%) 9/42(21.4%) 10/42(23.8%) 6/42(14.3%) 9/42(21.4%) 
    DSV 4.2 9/9(100%) 9/9(100%) 9/9(100%) 9/9(100%) 8/9(88.9%) 
    TCV 1.8 6/6(100%) 3/6(50%) 4/6(66.7%) 3/6(50%) 2/6(33.3%) 
    PDV 2.7 2/2(100%) 2/2(100%) 1/2(50%) 0 1/2(50%) 
   SV 0.4 1/1(100%) 1/1(100%) 1/1(100%) 1/1(100%) 1/1(100%) 
FTC 3.3 9/9(100%) 0 0 0 0 
MTC 0.8 4/6(66.7%) 0 3/6(50%) 3/6(50%) 1/6(16.7%) 
 
Tumor staging  The different stages of patients affected with DTC are 
showed in Figure 6.  
 
 
Among variants of PTC, CV demonstrated the majority of cases of 
T3(37/71, 52.1%) or T4 stages (2/71, 2.8%). Taking into account of 
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number of cases, DSV and FV respectively had the highest (9/9, 100%) 
and the least (14/42, 33.3%) proportion of T3 stage (Figure 7). 
 
 
 
 
 
PTC showed more lymph-node metastases (55/131, 42.0%) than FTC 
(0%) and MTC (16.7%). Unilateral or bilateral lymph-node metastases 
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metastases occurred in PTC cohort (Figure 8). 
The distribution of lymph-node metastases according to the different 
variants of PTC is shown in Figure 9. 
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Discussion 
It is difficult to determine the exact incidence of thyroid diseases in 
paediatric population because most published reports only focus on one 
of the many thyroid conditions. 
In our series, the main indications for thyroid surgery in the paediatric 
patients are oncological: most of the patients underwent surgery for either 
thyroid cancer or adenoma, whereas Graves’ disease and symptomatic 
nodular goiter account for a relative minority of patients. The number of 
thyroid cancer accounts for more than half of all thyroid diseases.  
A result that is immediately evident from our experience is the 
confirmation of the significant predominance of the female population 
among paediatric patients who necessitated surgery. This result not only 
confirms the literature, but also mirrors the predominance demonstrated 
in the adult population. When further analyzing the different age groups, 
the results show a progressive incidence of surgery, 
When dealing with the benign diseases requiring surgery, Graves’ disease 
(GD) is the most common cause of hyperthyroidism in children and 
adults. In children, the incidence is believed to be between 1 ～
10:100,000 
[58, 59]
, and it accounts for 10～15% of thyroid disorders in 
patients younger than 18 years 
[4]
. It is rare in children younger than 5 and 
it reaches its peak in adolescent girls between 10 and 15 years of age 
[60]
. 
This epidemiology is entirely confirmed by our data: GD accounted for 
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13% of all surgical indications, and all the patients are located in the 10～
18 years-old age group (88.0% females), confirming that adolescent girls 
are the population at higher risk of suffering from GD. 
Current treatment approaches for GD include antithyroid drugs (ATDs), 
radioactive iodine (RAI) and surgery, which are therapies that have been 
used for more than five decades 
[61-66]
. When at operation all 33 patients 
with GD in our research had received treatment with antithyroid 
medications (range from 6 months to 3 years) whereas no child had 
received RAI. Half of GD cases relapsed after remissions while the other 
half had not achieved remissions. The guardians of the children chose to 
surgery because of worrying about the side effects from long-term 
treatment with antithyroid medications and RAI.  
The incidence of thyroid nodules in children is estimated to be 1% to 1.5% 
based on clinical examination
 [67]
. Risk factors for development of thyroid 
nodules include female sex, pubertal age, family history of thyroid 
disease and a history of a medical condition that may be steroid- or 
endocrine-related
 [68]
. In our database the cohort of thyroid nodules 
consisted of differentiated cancer, follicular adenoma and symptomatic 
nodular goiter. The predominance of female sex and pubertal age (12～18 
years) can also be observed in our paediatric patients with thyroid 
nodules. 
This female predominance in thyroid cancer (that is reported among 
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adults) is not observed in children younger than 11 years old and is less 
prominent in adolescents than in adults 
[69, 70]
. The sex distribution in our 
series is not confirmed the literatures. Compared with the age group ≤12 
years old (74.1%, n=27), more prominence is showed in adolescent-age 
group (82.3%, n=113).  
Surgery is confirmed an acceptable treatment for thyroid disorders in 
children. In our department the surgical team is consisted of experienced 
thyroid surgeons, anesthetists and nurses. No paediatric surgeon is 
involved. Postoperative hypocalcemia occurred in 37(37/147) patients 
with thyroid cancer, in 8(8/33) patients with GD and in 7(7/45) patients 
with adenoma. After management with supplemental oral calcium, all 
patients had normalization of calcium levels. No injuries to RLN were 
recorded. These acceptable results are due to the significant experience of 
the surgeons, and reflect the results reported in literature by tertiary care 
referral centers for thyroid surgery. It is now clear that experienced 
thyroid surgeons demonstrate significantly better results than 
non-experienced ones both in the adult and paediatric populations, and 
also allow to confirm that a paediatric surgeon is not essential when 
dealing with thyroid surgery cases in the paediatric age 
[1-3]
. 
Our series also confirm the epidemiology of paediatric thyroid cancer 
reported in literatures: PTC in 89.1%, FTC in 6.1% and MTC in 4.8%. 
Some tumor features observed in comparing PTC, FTC and MTC, such 
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as larger tumor size in FTC, and more tendency of thyroid capsule 
infiltration, mutifocality, bilarerality and lymph-node involvement in PTC, 
mirrored the features of differentiated thyroid carcinoma in the adult 
population. But this similarity may be influenced by the following biases: 
1) the small number of cases for the FTC and MTC categories and, 2) 
nearly all MTC patients were either in an early stage of the MTC or were 
operated on with a prophylactic intent.  
PTC is the most common thyroid malignancy. Over the past twenty years, 
many morphologic variants of PTC have been described. Each variant 
shows a combination of specific growth patterns, cell types and stromal 
changes. A major problem in classifying PTC into various subtypes is that 
the criteria used to define these subtypes are not rigorously defined, and 
different pathologists may not agree with these subtype classifications. 
There is general agreement that the subtype classification that is used 
should constitute the predominant pattern of the neoplasm 
[71]
. According 
to our postoperative histological diagnosis, six variants were described: 
CV, FV, DSV, TCV, PDV and SV. These variants demonstrate a range of 
biologic aggressiveness, despite an overall favorable outcome for all 
variants. At present the published literatures concentrate on the variants of 
PTC in the adult population, and only few studies describe the variants of 
PTC in paediatric patients.  
In the adults, the FV is the most common variant of papillary thyroid 
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carcinoma after the classical one 
[72]
. Compared to CV, the follicular one 
tends to show benign features at ultrasonography and undetermined 
results at cytology 
[72]
. Our series shows that the paediatric population has 
similar preoperative features. The classic and the follicular variants, in 
our paediatric population, CV and FV account for the 54.2% and 32.1% 
of the whole series of PTC, respectively. FV showed less malignant 
features than the other variants: a smaller mean tumor size, and a lower 
incidence of tumor capsule infiltration, thyroid capsule infiltration, 
mutifocality, bilaterality and lymph node metastases. 
The DSV is a relatively rare variant and constituted the 0.74% of the 
whole PTC in large cohort of the whole PTC 
[73].
 Compared with the other 
variants of PTC, the patients with DSV showed younger age, larger tumor 
size and higher incidence of lymph node metastases, but the prognosis 
appeared to be as good as that of the classical variant 
[73]
. Another study 
showed that in the adult population, multifocality, bilaterality, and 
extrathyroidal extension were more frequently noted in DSV than in CV 
and, the outcome in such patients was worse than in those with low-risk 
CV, and similar to that of patients with high-risk CV 
[74]
. In our series of 
PTC, the incidence of DSV was 6.9%, which seems relatively high. This 
result may be biased by this relatively small series, but also by the lacking 
of absolute criteria to define the DSV at present 
[71]
. Overall, the 
diffuse-sclerosing variant is reported to have the most invasive features 
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among all variants: the largest mean tumor size, and highest incidence of 
tumor capsule infiltration, thyroid capsule infiltration, multifocality, 
bilaterality and lymph node metastases. 
The tall-cell variant is another aggressive form of PTC. It represents 8.3% 
of PTC, as reported in a large cohort, and shows more aggressiveness 
than the CV, because of a later stage at presentation, and an increased 
grade 
[75, 76]
. In the adult population, most patients with TCV are 
diagnosed in an older age, and present with large and bulky tumors, with 
a more aggressive course than the other PTC variants 
[77-80]
. Some 
surgeons believe that there is no relationship between TCV histology and 
recurrence or mortality 
[75, 76]
, other reports shows that this variant alone 
remains a significant prognostic factor for disease-specific death 
[81]
. In 
our series, the TCV represents the 4.6% of all PTCs and shows a higher 
incidence of tumor capsule infiltration, thyroid capsule infiltration, 
mutifocality, bilaterality, but lower rate of lymph-node metastases when 
compared to the CV.  
TNM is the most widely used staging system for cancer at present. In 
analyzing stage distribution of differentiated thyroid carcinoma in 
children, we found that PTC has the largest incidence of T3 or T4 stages 
(50.6%). When further analyzing this result, we also found that 10% of 
PTC was diagnosed as T3 because of diameter more than 4 cm, and the 
other 40.6% of the advanced stage was due to extrathyroidal infiltration 
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to soft tissues, muscles, larynx, trachea, esophagus, recurrent laryngeal 
nerve or important vessels. This clearly reflects the fact that PTC in the 
paediatric patients has a greater incidence of local aggressiveness, if 
compared to the adult population. When looking at the different variants, 
CV accounts for the majority of T3 or T4 stages, but when we take into 
account the relative numbers, DSV is diagnosed at higher stages than the 
other variants, while FV shows the least extrathyroidal infiltration. 
In our study, 52% of PTC patients presented with a preoperative 
suspicion of lymph-node involvement, on the basis of either an US or 
FNA, or both, and for this reason a lymph-node dissection was performed 
during surgery. The final histology confirmed the presence of the node 
metastases in 80% of these cases. Among lymph-node positive patients, 
74.5% involved at least one lateral neck compartment, and this suggests 
that PTC in paediatric patients has more tendency for a lateral 
lymph-node involvement than the adult population. When looking at the 
different variants, CV presented similar tendency for lymph-node 
metastases with the whole cohort of PTC patients in out paediatric 
population. DSV and FV showed the highest and lowest tendency for 
lymph-node metastases, respectively.   
A relatively small number of subjects with follicular or medullary 
carcinoma are present in our study, so no further analysis could be done 
to evaluate these relatively rare cancer groups in our population. 
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Nevertheless, we can easily find that most of the MTC cases showed a 
smaller tumor size, with less aggressive features, a presentation at an 
earlier stage, and a rare lymph node involvement, when compared to the 
adult population. The routine preoperative testing of basal calcitonin, 
stimulating calcitonin (when indicated), and also of the mutation test for 
the RET proto-oncogene (in suspicious familial disease), is the reason 
behind the early diagnosis of MTC. When a real prophylactic surgery was 
performed, the aggressive features of MTC could not be observed, and 
patients will reasonably demonstrate much better outcomes. 
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Conclusions  
Indications for thyroidectomy in paediatric patients include thyroid cancer, 
Graves’ disease and non-cancerous nodules, and thyroid cancer accounts 
for the majority of the indications. Among the paediatric population, 
female sex and pubertal age are the most common targets for thyroid 
disorders. Female sex and pubertal age are risk factors of paediatric 
thyroid disorders. A paediatric surgeon is not essential when dealing with 
thyroid surgery in children, but the results are affected by the experience 
of the surgeon dealing with thyroid surgery. 
From an oncological point of view, our study confirms that papillary 
thyroid carcinoma in children shows more aggressiveness, higher stage at 
presentation, and is more prone to present with lymph-node metastases 
than both follicular and medullary thyroid carcinoma, and than the same 
disease in the adult population. In particular, the diffuse sclerosing variant 
shows the most aggressive features, and the follicular one seems to have 
the less aggressive features. 
 
 
 
 
 
 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
35 
 
References 
1. Solorzano CC, Sosa JA, Lechner SC, Lew JI, Roman SA. Endocrine 
surgery: where are we today? A national survey of young endocrine 
surgeons. Surgery. 2010 Apr; 147 (4):536-41. 
2. Wang TS, Roman SA, Sosa JA. Predictors of outcomes following 
paediatric thyroid and parathyroid surgery. Curr Opin Oncol. 2009 Jan; 
21 (1):23-8. 
3. Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees 
S, Roman SA. Clinical and economic outcomes of thyroid and 
parathyroid surgery in children. J Clin Endocrinol Metab. 2008 Aug; 93 
(8):3058-65. 
4. Bauer AJ (2011) Approach to the paediatric patient with Graves’ 
disease: When is definitive therapy warranted? J Clin Endocrinol Metab 
96(3):580–588. 
5. Barnes HV, Blizzard RM (1977) Antithyroid drug therapy for toxic 
diffuse goiter (Graves’ disease): thirty years experience in children and 
adolescents. J Pediatr 91(2):313–320. 
6. Barrio R, Lopez-Capape M, Martinez-Badas I, Carrillo A, Moreno JC, 
Alonso M (2005) Graves’ disease in children and adolescents: response to 
long-term treatment. Acta Paediatr 94(11):1583–1589. 
7. Gorton C, Sadeghi-Nejad A, Senior B (1987) Remission in children 
with hyperthyroidism treated with propylthiouracil. Long-term results. 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
36 
 
Am J Dis Child 141(10):1084–1086. 
8. Hamburger JI (1985) Management of hyperthyroidism in children and 
adolescents. J Clin Endocrinol Metab 60(5):1019–1024. 
9. Raza J, Hindmarsh PC, Brook CG (1999) Thyrotoxicosis in children: 
thirty years’ experience. Acta Paediatr 88(9):937–941. 
10. Lippe BM, Landaw EM, Kaplan SA (1987) Hyperthyroidism in 
children treated with long term medical therapy: twenty-five percent 
remission every two years. J Clin Endocrinol Metab 64 (6): 1241 – 1245. 
11. Read CH Jr, Tansey MJ, Menda Y. A 36-year retrospective analysis of 
the efficacy and safety of radioactive iodine in treating young Graves' 
patients. J Clin Endocrinol Metab. 2004 Sep; 89 (9): 4229 - 33. 
12. Boice JD Jr. Radiation and thyroid cancer: what more can be learned? 
Acta Oncol. 1998; 37 (4):321-4. PubMed PMID:9743452 
13. Boice JD Jr. Thyroid disease 60 years after Hiroshima and 20 years 
after Chernobyl. JAMA. 2006 Mar 1; 295 (9):1060-2. 
14. Dolphin GW. The risk of thyroid cancers following irradiation. Health 
Phys. 1968 Sep; 15 (3):219-28. 
15. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Treatment 
of Graves' hyperthyroidism with radioiodine: results of a prospective 
randomized study. Thyroid. 1997 Apr;7 (2):247-51. 
16. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Reduction 
in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
37 
 
results of a prospective, randomized, multicentre study. Eur J Clin Invest. 
1996 Jan; 26(1):59-63. 
17. Netterville JL, Aly A, Ossoff RH. Evaluation and treatment of 
complications of thyroid and parathyroid surgery. Otolaryngol Clin North 
Am. 1990 Jun; 23 (3):529-52. 
18. Ansaldo GL, Pretolesi F, Varaldo E, Meola C, Minuto M, Borgonovo 
G, Derchi LE, Torre GC. Doppler evaluation of intrathyroid arterial 
resistances during preoperative treatment with Lugol's iodide solution in 
patients with diffuse toxic goiter. J Am Coll Surg. 2000 Dec; 191 
(6):607-12. 
19. Erbil Y, Ozluk Y, Giriş M, Salmaslioglu A, Issever H, Barbaros U, 
Kapran Y, Ozarmağan S, Tezelman S. Effect of lugol solution on thyroid 
gland blood flow and microvessel density in the patients with Graves' 
disease. J Clin Endocrinol Metab. 2007 Jun; 92 (6):2182-9. 
20. Delbridge L. Total thyroidectomy: the evolution of surgical technique. 
ANZ J Surg. 2003 Sep; 73 (9):761-8. 
21. Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle 
H. The impact of surgical technique on postoperative hypoparathyroidism 
in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive 
patients. Surgery. 2003 Feb; 133 (2): 180-5. 
22. Millman B, Pellitteri PK. Thyroid carcinoma in children and 
adolescents. Arch Otolaryngol Head Neck Surg 1995; 121(11): 1261-4. 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
38 
 
23. Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, 
Adair C, Francis GL. Clinical features associated with metastasis and 
recurrence of differentiated thyroid cancer in children, adolescents and 
young adults. Clin Endocrinol (Oxf). 1998 Nov; 49 (5):619-28. 
24. Reiners C, Demidchik YE. Differentiated thyroid cancer in childhood: 
pathology, diagnosis, therapy. Pediatr Endocrinol Rev. 2003 Dec; 1 Suppl 
2:230-5; discussion 235-6.  
25. Chaukar DA, Rangarajan V, Nair N, Dcruz AK, Nadkarni MS, Pai PS, 
Mistry RC. Paediatric thyroid cancer. J Surg Oncol. 2005 Nov 1; 92 
(2):130-3. 
26. Okada T, Sasaki F, Takahashi H, Taguchi K, Takahashi M, Watanabe 
K, Itoh T, Ota S, Todo S. Management of childhood and adolescent 
thyroid carcinoma: long-term follow-up and clinical characteristics. Eur J 
Pediatr Surg. 2006 Feb; 16 (1):8-13. 
27. Thompson GB, Hay ID. Current strategies for surgical management 
and adjuvant treatment of childhood papillary thyroid carcinoma. World J 
Surg. 2004 Dec; 28 (12) :1187-98. 
28. O'Gorman CS, Hamilton J, Rachmiel M, Gupta A, Ngan BY, 
Daneman D. Thyroid cancer in childhood: a retrospective review of 
childhood course. Thyroid. 2010 Apr; 20 (4):375-80. 
29. Rachmiel M, Charron M, Gupta A, Hamilton J, Wherrett D, Forte V, 
Daneman D. Evidence-based review of treatment and follow up of 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
39 
 
paediatric patients with differentiated thyroid carcinoma. J Pediatr 
Endocrinol Metab. 2006 Dec; 19 (12):1377-93. 
30. Luster M, Lassmann M, Freudenberg LS, Reiners C. Thyroid cancer 
in childhood: management strategy, including dosimetry and long-term 
results. Hormones (Athens). 2007 Oct-Dec; 6 (4):269-78. 
31. Dinauer C, Francis GL. Thyroid cancer in children. Endocrinol Metab 
Clin North Am. 2007 Sep; 36 (3):779-806, vii. 
32. Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in 
children: diagnosis and management. Curr Opin Oncol. 2008 Jan; 20 
(1):59-65. 
33. Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, 
McConahey WM. Papillary thyroid carcinoma in children and adults: 
long-term follow-up of 1039 patients conservatively treated at one 
institution during three decades. Surgery. 1988 Dec; 104 (6): 1157-66. 
34. Zaydfudim V, Feurer ID, Griffin MR, Phay JE. The impact of 
lymph-noede involvement on survival in patients with papillary and 
follicular thyroid carcinoma. Surgery. 2008 Dec; 144 (6):1070-7; 
discussion 1077-8. 
35. Hung W, Sarlis NJ. Current controversies in the management of 
paediatric patients with well-differentiated nonmedullary thyroid cancer: 
a review. Thyroid. 2002 Aug; 12 (8):683-702. 
36. Schlumberger M, De Vathaire F, Travagli JP, Vassal G, Lemerle J, 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
40 
 
Parmentier C, Tubiana M. Differentiated thyroid carcinoma in childhood: 
long term follow-up of 72 patients. J Clin Endocrinol Metab. 1987 Dec; 
65 (6):1088-94. 
37. Lazar L, Lebenthal Y, Steinmetz A, Yackobovitch-Gavan M, Phillip 
M. Differentiated thyroid carcinoma in paediatric patients: comparison of 
presentation and course between pre-pubertal children and adolescents. J 
Pediatr. 2009 May; 154 (5):708-14. 
38. Machens A, Lorenz K, Nguyen Thanh P, Brauckhoff M, Dralle H. 
Papillary thyroid cancer in children and adolescents does not differ in 
growth pattern and metastatic behavior. J Pediatr. 2010 Oct; 157 
(4):648-52. 
39. Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, et al. 
Consensus statement on the terminology and classification of central neck 
dissection for thyroid cancer. Thyroid. 2009 Nov; 19 (11):1153-8. 
40. Udelsman R, Lakatos E, Ladenson P. Optimal surgery for papillary 
thyroid carcinoma. World J Surg. 1996 Jan; 20 (1) :88-93 
41. Udelsman R. Thyroid cancer surgery. Rev Endocr Metab Disord. 
2000 Apr; 1 (3):155-63. 
42. Miller BS, Doherty GM. An examination of recently revised 
differentiated thyroid cancer guidelines. Curr Opin Oncol. 2011 Jan; 23 
(1):1-6. 
43. Mazzaferri EL. A vision for the surgical management of papillary 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
41 
 
thyroid carcinoma: extensive lymph-noede compartmental dissections 
and selective use of radioiodine. J Clin Endocrinol Metab. 2009 Apr; 94 
(4):1086-8. 
44. Doherty GM. Prophylactic central lymph-noede dissection: continued 
controversy. Oncology (Williston Park). 2009 Jun; 23 (7): 603-8. 
45. Gimm O, Rath FW, Dralle H. Pattern of lymph-noede metastases in 
papillary thyroid carcinoma. Br J Surg. 1998 Feb; 85 (2):252-4. 
46. Bonnet S, Hartl D, Leboulleux S, et al. Prophylactic lymph-noede 
dissection for papillary thyroid cancer less than 2 cm: implications for 
radioiodine treatment. J Clin Endocrinol Metab. 2009 Apr; 94 (4):1162-7. 
47. Bonnet S, Hartl DM, Travagli JP. Lymph-noede dissection for thyroid 
cancer. J Visc Surg. 2010 Jun; 147 (3):e155-9. 
48. Pereira JA, Jimeno J, Miquel J, et al. Nodal yield, morbidity, and 
recurrence after central neck dissection for papillary thyroid carcinoma. 
Surgery. 2005; 138 (6):1095-100, discussion 1100- 1. 
49. Shindo M, Stern A. Total thyroidectomy with and without selective 
central compartment dissection: a comparison of complication rates. Arch 
Otolaryngol Head Neck Surg. 2010 Jun; 136 (6):584-7. 
50. Giles Y, Boztepe H, Terzioglu T, Tezelman S. The advantage of total 
thyroidectomy to avoid reoperation for incidental thyroid cancer in 
multinodular goiter. Arch Surg. 2004 Feb; 139 (2):179-82. 
51. M. A. Kouvaraki, S. E. Shapiro, N. D. Perrier et al., “RET proto- 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
42 
 
oncogene: a review and update of genotype-phenotype correlations in 
hereditary medullary thyroid cancer and associated endocrine tumors,” 
Thyroid, vol. 15, no. 6, pp. 531–544, 2005. 
52. J. R. Hansford and L. M. Mulligan, “Multiple endocrine neoplasia 
type 2 and RET: from neoplasia to neurogenesis,” Journal of Medical 
Genetics, vol. 37, no. 11, pp. 817–827, 2000. 
53. T. Kahraman, J. W. B. de Groot, C. Rouwe et al., “Acceptable age for 
prophylactic surgery in children with multiple endocrine neoplasia type 
2a,” European Journal of Surgical Oncology, vol. 29, no. 4, pp. 331–335, 
2003. 
54. R. T. Kloos, C. Eng, D. B. Evans et al., “Medullary thyroid cancer: 
management guidelines of the American Thyroid Association,” Thyroid, 
vol. 19, no. 6, pp. 565–612, 2009. 
55. C. J. M. Lips, J. W. M. H¨oppener, and J. H. H. Thijssen, “Medullary 
thyroid carcinoma: role of genetic testing and calcitonin measurement,” 
Annals of Clinical Biochemistry, vol. 38, no. 3, pp. 168–179, 2001. 
56. Halac I, Zimmerman D. Thyroid nodules and cancers in children. 
Endocrinol Metab Clin North Am. 2005 Sep; 34 (3):725-44, x. 
57. Glaser NS, Styne DM, Organization of Paediatric Endocrinologists of 
Northern California Collaborative Graves' Disease Study Group. 
Predicting the likelihood of remission in children with Graves' disease: a 
prospective, multicenter study. Paediatrics. 2008 Mar; 121 (3):e481-8. 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
43 
 
58. Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees 
S, Roman SA. Clinical and economic outcomes of thyroid and 
parathyroid surgery in children. J Clin Endocrinol Metab. 2008 Aug; 93 
(8):3058-65. 
59. Lavard L, Ranlov I, Perrild H, Andersen O, Jacobsen BB (1994) 
Incidence of juvenile thyrotoxicosis in Denmark, 1982–1988. A 
nationwide study. Eur J Endocrinol 130(6):565–568. 
60. Kaguelidou F, Alberti C, Castanet M, Guitteny MA, Czernichow P, 
Leger J (2008) Predictors of autoimmune hyperthyroidism relapse in 
children after discontinuation of antithyroid drug treatment. J Clin 
Endocrinol Metab 93(10):3817–3826. 
61. Weetman AP. Graves’ disease 1835-2002. Horm Res. 2003;59 Suppl 
1:114-8. 
62. Weetman AP. Graves’ disease. N Engl J Med. 2000 Oct 26; 343(17): 
1236-48. 
63. Chapman EM. History of the discovery and early use of radioactive 
iodine. JAMA. 1983 Oct 21; 250(15):2042-4. 
64. Cooper DS. Antithyroid drugs. N Engl J Med. 2005 Mar 3; 352(9): 
905-17. 
65. Gruñeiro-Papendieck L, Chiesa A, Finkielstain G, Heinrich JJ. 
Paediatric Graves' disease: outcome and treatment. J Pediatr Endocrinol 
Metab. 2003 Dec; 16(9):1249-55. 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
44 
 
66. Rivkees SA, Sklar C, Freemark M. Clinical review 99: The 
management of Graves' disease in children, with special emphasis on 
radioiodine treatment. J Clin Endocrinol Metab. 1998 Nov; 83 
(11):3767-76. 
67. Wartofsky L. The thyroid nodule. In: Wartofsky L, editor. Thyroid 
cancer: a comprehensive guide to clinical management. Totowa (NJ): 
Humana Press; 2000. p. 3-7. 
68. Fowler CL, Pokorny WJ, Harberg FJ. Thyroid nodules in children: 
current profile of a changing disease. South Med J 1989; 82 (12): 1472-8. 
69. Harach HR, Williams ED. Childhood thyroid cancer in England and 
Wales. Br J Cancer. 1995 Sep; 72 (3):777-83. 
70. Zimmerman D. Thyroid tumors. In: Lifshitz F, editor. Paediatric 
endocrinology. New York:Marcel Dekker; 2003. p. 407-20. 
71. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma 
variants. Head Neck Pathol. 2011 Mar; 5 (1) :51-6. 
72. Ozdemir D, Ersoy R, Cuhaci N, et al. Classical and follicular variant 
papillary thyroid carcinoma: comparison of clinical, ultrasonographical, 
cytological, and histopathological features in 444 patients. Endocr Pathol. 
2011 Jun; 22 (2):58-65. 
73. Chow SM, Chan JK, Law SC, Tang DL, Ho CM, Cheung WY, Wong 
IS, Lau WH. Diffuse sclerosing variant of papillary thyroid 
carcinoma--clinical features and outcome. Eur J Surg Oncol. 2003 Jun; 29 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
45 
 
(5):446-9. 
74. Regalbuto C, Malandrino P, Tumminia A, Le Moli R, Vigneri R, 
Pezzino V. A diffuse sclerosing variant of papillary thyroid carcinoma: 
clinical and pathologic features and outcomes of 34 consecutive cases. 
Thyroid. 2011 Apr; 21 (4):383-9. 
75. Michels JJ, Jacques M, Henry-Amar M, Bardet S. Prevalence and 
prognostic significance of tall cell variant of papillary thyroid carcinoma. 
Hum Pathol. 2007 Feb; 38 (2):212-9. 
76. Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I. Tall-cell 
variant of papillary thyroid carcinoma: a matched-pair analysis of 
survival. Thyroid. 2010 Feb; 20 (2):153-8. 
77. Khan A, Nose V. In: Lloyd RV, editor. Endocrine pathology: 
differential diagnosis and molecular advances, 2
nd
 ed. New York: Springer 
2010; p. 181–236. 
78. DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. Pathology and 
genetics of tumours of endocrine organs. In: Kleihues P, Sobrin LH, 
series editors. World health organization. Classification of Tumours. Lyon: 
IARC Press; 2004. 
79. Hawk WA, Hazard JB. The many appearances of papillary carcinoma 
of the thyroid. Cleve Clin Q. 1976;43: 207–15. 
80. Johnson TL, Lloyd RV, Thompson NW, et al. Prognostic implications 
of the tall cell variant of papillary thyroid carcinoma.Am J Surg Pathol. 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
46 
 
1988;12: 22–7. 
81. Prendiville S, Burman KD, Ringel MD, Shmookler BM, Deeb ZE, 
Wolfe K, Azumi N, Wartofsky L, Sessions RB. Tall cell variant: an 
aggressive form of papillary thyroid carcinoma. Otolaryngol Head Neck 
Surg. 2000 Mar; 122 (3):352-7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
47 
 
Acknowledgement 
This work has been done in the Department of General Surgery, 
University of Pisa. 
In the first place I would like to express my deep and sincere gratitude to 
my two supervisors, Prof. Paolo Miccoli and Doctor Michele Minuto. 
Their supervision, advices, and guidance throughout the three years 
allowed me to develop my research work. Without them this thesis could 
not be completed. Special thanks to my friend Michele Minuto for his 
help, kindness and encouragement during my stay in Italy. 
I am also grateful to Prof. Claudio Spinelli for his support in finishing this 
research. 
I am especially grateful to Ms. Maria Teresa Del Bravo for her great help 
and kindness.  
Many thanks to Ms. Elena Paoli and her colleagues in the secretary office 
for what they have done for me all these three years. 
Special thanks to Doctor Gabriele Materazzi for his help in work and in 
publishing the paper about laparoscopic thyroid surgery.  
Many thanks to my Chinese colleague Dan Bai for her help in work and 
daily life.  
DOCTORAL DISSERTATION                                                      UNIVERSITY OF PISA  
 
48 
 
Thanks to Doctor Valeria Matteucci for his support in this work. 
My gratitude goes to my Italian colleagues and friends in the surgical 
center of General Surgical Department II. Their help and encouragement 
in work and life make my stay in Italy delightful.  
I am grateful for the financial support provided by China Scholarship 
Council. Many thanks to Mr. Hongjian Wang of Embassy of PRC in Italy 
for his help during my stay in Italy. 
Special and sincere gratitude to Miss Na Du for her help, advice and care 
to me during this work and my daily life.  
Finally, I express my gratitude to my parents and the whole family. All 
the time their support, understanding and encouragement make me 
advance bravely, and never lose my goal and feel lonely. I love them. 
Here I send my sincere and best wishes to them.   
 
